Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $1.3 Million Underwritten Public Offering for SciSparc Ltd.

Press Release – New York, NY – August 15, 2023 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. in the $1.3 Million underwritten public offering of SciSparc Ltd., a clinical-stage pharmaceutical company. The base offering consisted of 6,500,000 ordinary shares (or pre-funded warrants in lieu of ordinary shares) at a price to the public of $0.20 per share (or $0.199 per pre-funded warrant). The gross proceeds of the offering to the company were approximately $1.3 million.

This offering was made pursuant to an effective shelf registration statement on Form F-3 (No. 333- 269839) declared effective by the Securities and Exchange Commission on February 23, 2023. The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Jeff Cahlon and Barrett DiPaolo, and associate Mayank Pradhan.